Viewing Study NCT00516802

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-02-24 @ 3:43 PM
Study NCT ID: NCT00516802
Status: COMPLETED
Last Update Posted: 2009-05-15
First Post: 2007-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Poly(ADP ribose) polymerases View
None dacarbazine View